Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE915B01019
Sector:
Healthcare
Symbol:
INDSWFTLAB
Ind-Swift Laboratories Limited
₹87.50
₹-0.90
(-1.02%)
▼
Prev. Close
₹88.40
Open
₹89.75
Close
₹87.62
Range
₹83.13 - ₹91.88
High
₹91.38
Low
₹87.10
Ind. Close
₹0.00
VWAP
₹88.56
The current stock price of Ind-Swift Laboratories Limited is ₹87.50, with a target price range between ₹83.13 and ₹91.88. The stock has experienced a price change of ₹-0.90 (-1.02%), reflecting recent market volatility.
Today's opening price was ₹89.75, while the previous close stood at ₹88.40.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Ind-Swift Laboratories Limited Price Chart
Ind-Swift Laboratories Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 89.75
- Previous Close Price: 88.4
- Change: 1.35%
- Total Traded Volume: 361
- Total Buy Quantity: 4,392
- Total Sell Quantity: 3,492
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 87.21 | 1.00 | 0.00 |
| 88.10 | 100.00 | 0.00 |
| 88.40 | 520.00 | 0.00 |
| 88.50 | 300.00 | 0.00 |
| 88.65 | 200.00 | 0.00 |
| 89.75 | 0.00 | 19.00 |
| 90.15 | 0.00 | 50.00 |
| 90.99 | 0.00 | 1.00 |
| 91.95 | 0.00 | 600.00 |
| 92.00 | 0.00 | 851.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 4392
Total Sell Quantity: 3492
Shareholding Patterns of Ind-Swift Laboratories Limited
Key Trade Statistics of Ind-Swift Laboratories Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 1.93 |
| Traded Value (₹ Cr.) | 1.71 |
| Total Market Cap (₹ Cr.) | 517.01 |
| Free Float Market Cap (₹ Cr.) | 296.43 |
| Impact cost | 0.76 |
| Quantity Traded | 192,530.00 |
| Deliverable Quantity | 108,703.00 |
| % of Quantity to Traded | 56.46 |
| Security VaR | 21.97 |
| Index VaR | N/A |
| VaR Margin | 21.97 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 25.47 |
| Face Value | 10 |
Key Price Statistics of Ind-Swift Laboratories Limited
The 52-week high for Ind-Swift Laboratories Limited was ₹186.00, recorded on 02-Aug-2024. On the other hand, the 52-week low stands at ₹81.47, with the lowest value recorded on 04-Mar-2025.
The upper band for trading is ₹106.08, and the lower band is ₹70.72. The price band is 20%.
The stock's daily volatility stands at 3.31, while the annualized volatility is 63.24. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (02-Aug-2024) | 186.00 |
| 52 Week Low (04-Mar-2025) | 81.47 |
| Upper Band | 106.08 |
| Lower Band | 70.72 |
| Price Band (%) | 20 |
| Daily Volatility | 3.31 |
| Annualised Volatility | 63.24 |
| Tick Size | 0.01 |
Key Securities Statistics of Ind-Swift Laboratories Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 02-Jul-1997 |
| Adjusted P/E | 124.68 |
| Symbol P/E | 2.15 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Ind-Swift Laboratories Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Ind-Swift Laboratories Limited
| Subject | Date |
|---|---|
| Updates | 11-Mar-2025 |
| General Updates | 25-Feb-2025 |
| Shareholders meeting | 25-Feb-2025 |
| Shareholders meeting | 22-Feb-2025 |
| Shareholders meeting | 22-Feb-2025 |
| Monitoring Agency Report | 14-Feb-2025 |
| Integrated Filing- Financial | 13-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 13-Feb-2025 |
Corporate Actions of Ind-Swift Laboratories Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 24-Sep-2024 |
| 10 | Annual General Meeting | 22-Sep-2023 |
| 10 | Annual General Meeting | 22-Sep-2022 |
| 10 | Annual General Meeting | 23-Sep-2021 |
| 10 | Annual General Meeting | 23-Sep-2020 |
| 10 | Annual General Meeting | 24-Sep-2019 |
| 10 | Annual General Meeting | 19-Sep-2018 |
| 10 | Annual General Meeting | 14-Sep-2017 |
| 10 | Annual General Meeting | 20-Sep-2016 |
| 10 | Annual General Meeting | 18-Sep-2015 |
| 10 | Annual General Meeting | 18-Sep-2014 |
| 10 | Annual General Meeting | 24-Sep-2013 |
| 10 | Annual General Meeting | 21-Sep-2012 |
| 10 | Annual General Meeting And Dividend Re.1/- Per Share | 20-Sep-2011 |
| 10 | Annual General Meeting And Dividend Re.1/- Per Share | 16-Sep-2010 |
| 10 | Agm/Div-Rs.1/- Per Share | 17-Sep-2009 |
| 10 | Agm/Dividend - 10% | 18-Sep-2008 |
| 10 | Agm/Dividend-10% | 21-Sep-2007 |
| 10 | Agm/Dividend-15% | 22-Sep-2006 |
| 10 | Agm/Dividend-15% | 22-Sep-2005 |
Board Meetings of Ind-Swift Laboratories Limited
Financial Results of Ind-Swift Laboratories Limited
Company Directory of Ind-Swift Laboratories Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.indswiftlabs.com | Head Office/ Corporate Office | SCO No. 850, 2nd Floor Shivalik Enclave, N.A. C Manimajra | CHANDIGARH |
| www.indswiftlabs.com | Registered Office | SCO 850, Shivalik Enclave NAC, Manimajra | CHANDIGARH |
| www.indswiftlabs.com | Transfer Agent | M/s Alankit Assignments Limited 205-208, Anarkali Market, Jhandewalan Extention, | NEW DELHI |
Insider Trading of Ind-Swift Laboratories Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | GAGAN AGGARWAL | 4242228 | Sell |
| 7(2) | ATUL KUMAR CHAUBEY | 3319678 | Sell |
| 7(2) | RAJESH NAG | 1878400 | Sell |
| 7(2) | SATISH SHARMA | 1067707 | Sell |
| 7(2) | LOVEKESH MAHAJAN | 1080000 | Sell |
| 7(2) | LOVEKESH MAHAJAN | 1566792 | Sell |
| 7(2) | Neha Verma | 3263000 | Buy |
| 7(2) | PRADEEP KUMAR GOEL | 960000 | Sell |
| 7(2) | PRADEEP KUMAR GOEL | 1233000 | Sell |
| 7(2) | PRADEEP KUMAR GOEL | 1643972 | Sell |
| 7(2) | ANURAG CHATURVEDI | 499200 | Sell |
| 7(2) | ANURAG CHATURVEDI | 745604 | Sell |
| 7(2) | ANURAG CHATURVEDI | 746000 | Sell |
| 7(2) | ANURAG CHATURVEDI | 499200 | Sell |
| 7(2) | ANURAG CHATURVEDI | 745604 | Sell |
| 7(2) | ANURAG CHATURVEDI | 746000 | Sell |
| 7(2) | VIJAY KUMAR | 1044000 | Sell |
| 7(2) | RAJESH NAG | 1422000 | Sell |
| 7(2) | RAJESH NAG | 1700000 | Sell |
| 7(2) | LALIT KUMAR WADHWA | 433750 | Sell |
Annual Reports of Ind-Swift Laboratories Limited
Investor Complaints of Ind-Swift Laboratories Limited
Event Calendar of Ind-Swift Laboratories Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To transact inter-alia among other items the following business : (1) To adopt Annual Audited Accounts for the financial year ended March 31, 2010; (2) To consider declaration of dividend, if any, approved by the Board on equity shares of the Company; (3) To consider & approve allotment of equity shares upon conversion of warrants (Series 2009) into equity shares. |
| Issue of Securities | Inter-alia among other items the following matter: 1) To fixation of the date of Annual General Meeting and other related items. 2) Fresh preferential Issue of Convertible warrants to Promoters Group. |
| Results/Others | To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010. |
| Board meeting Rescheduled | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on November 08, 2010 To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010. The Company has now informed the Exchange that the Board Meeting of the Company is scheduled to be held on November 13, 2010 to consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010. |
| Results/Others | To transact inter-alia among other items the following business : (1) Quarterly Unaudited Financial Results (Provisional) for the Quarter ended December 31, 2010; (2) To consider & approve allotment of equity shares upon conversion of warrants (Series 2009) into equity shares. |
| Results/Dividend | To transact inter-alia among other items the following business : (1) To adopt Annual Audited Accounts for the financial year ended March 31, 2011; (2) To consider declaration of dividend, if any, approved by the Board on the equity shares of the Company; (3) Allotment of Shares under Employee Stock Option Plans (ESOP). |
| Results/Others | To consider, interalia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2011. |
| Results/Dividend | To transact inter-alia among other items the following business: (1) To adopt Annual Audited Accounts for the financial year ended March 31, 2012; (2) To consider declaration of dividend if any, approved by the Board on the equity shares of the Company; (3) Allotment of equity shares under Employee Stock Option Plan (ESOP). |
| Results/Others | To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2012. |
| Results/Others | To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2012. |
| Board Meeting Postponed | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on February 12, 2013 to consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2012. The Company has now informed that due to some unavoidable circumstances, the aforesaid Board Meeting has been postponed and will now be held on February 13, 2013. |
| Results/Others | To consider inter-alia among other items, the Annual Audited Accounts for the Financial Year ended March 31, 2013. |
| Results/Others | To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2013. |
| Results/Others | The company had informed the Exchange that the meeting of the board of directors of the company is scheduled to be held on August 09, 2013 to consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2013. The company has now informed the Exchange that in the aforesaid meeting the board shall also consider Issue of shares on preferential basis to promoter directors and promoter group company in terms of CDR Package. (Purpose Revised). |
| Results | To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2013. |
| Board meeting Rescheduled | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on February 11, 2014 to consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2013. The Company has now informed the Exchange that due to some unavoidable circumstances, the aforesaid Board Meeting has been preponed to February 10, 2014. |
| Results | To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2013. |
| Results | To consider inter-alia among other items, the Audited Financial Results for the Quarter and Financial Year ended March 31, 2014. Further as per the Company s Code of Conduct for prevention of Insider Trading read with SEBI (Prohibition of Insider Trading) Regulation, 1992, the Trading Window for dealing in Equity Shares of the Company shall remain closed from May 20, 2014 to May 29, 2014 (both days inclusive) for the purpose of declaration of Audited Financial Results for the quarter and financial year ended March 31, 2014 on May 28, 2014 for all Directors / Officers / Designated Employees of the Company. The "Trading Window" shall reopen for dealing in the equity shares of the Company from the start of business hours on May 30, 2014 |
| Results/Others | To consider unaudited financial results for the quarter ended 30.06.2014 and issue of equity shares to promoters against the funds infused as per CDR scheme of the Company. |
| Results | To consider inter-alia among other items, the Unaudited Financial Results for the quarter ended September 30, 2014. |
| Results | To consider inter among other items, the Unaudited Financial Results for the quarter ended December 31, 2014. |
| Board Meeting Postponed | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held on February 6, 2015, to consider inter among other items, the Unaudited Financial Results for the quarter ended December 31, 2014. The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to February 7, 2015. (Revised). |
| Results | To consider inter-alia among other items, the Audited Financial Results for the Quarter and Financial Year ended March 31, 2015. |
| Results/Others | to consider inter-alia among other items, the Un-audited Financial Results for the quarter ended June 30, 2015. |
| Others | To consider preferential issue of shares to promoters in terms of CDR package of the Company. |
| Results | To consider inter-alia among other items, the Un-audited Financial Results for the quarter ended September 30, 2015. |
| Results/Others | To consider inter-alia among other items, the Un-audited Financial Results for the quarter ended December 31, 2015. |
| Results | to consider inter alia among other items, the Audited Financial Year and quarter ended March 31, 2016. |
| Results | To consider inter alia among other items the Un-audited financial results for the quarter ended June 30, 2016. |
| Results/Others | To consider inter-alia, the Un-audited Financial Results for the quarter and half year ended 30th September, 2016 and allotment of shares to the Promoter s Group on preferential basis against the Promoters contribution infused by the promoters under the CDR package of the Company. |
| Results | To consider and take on record inter alia the Un-audited financial results for the quarter ended December 31, 2016. |
| Results | To consider inter-alia among other items, the Audited Financial Results for the quarter and Financial Year ended March 31, 2017. |
| Results | To consider inter-alia among other items, the Un-Audited Financial Results for the quarter ended June 30, 2017 |
| Results | to consider inter alia among other items, the Un-audited Financial Results for the quarter and half year ended September 30, 2017. |
| Results/Others | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 13, 2018 To consider inter-alia among other items, the Un-audited Financial Results for the quarter ended December 31, 2017. The Company has now informed the Exchange that the Board will also consider the matter relating to raising of funds through Preferential Issue of Equity shares/ Convertible Warrants to persons/entities other than Promoters.(Purpose Revised). |
| Results/Others | To consider inter-alia among other items, the Un-audited Financial Results for the quarter ended December 31, 2017. |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | INDSWFTLAB : 30-May-2018 : The Company has informed the Exchange that a Board meeting to be held on May 28, 2018 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2018, To consider and approve the financial results for the period ended March 31, 2018 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Other business matters | To consider & Approve allotment of Non-Convertible Debentures to the prospective allottees on Private placement basis through EBP Mechanism as per the approval granted by the shareholders in their Extra Ordinary General meeting held on March 28, 2018. |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2019 |
| Other business matters | To consider inter-alia among other items, the conversion of Optionally Convertible Debentures (OCDs) into Equity Shares of the Company. |
| Financial Results | Board Meeting of the Company is scheduled to be held on 13.02.2020 to consider inter-alia among other items, the Standalone and Consolidated Un-audited financial results for the quarter and nine months ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the Un-Audited Standalone and Consolidated financial results for the Quarter ended June 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | INDSWFTLAB : 29-Jun-2021 : The Company has informed the Exchange that a Board meeting to be held on Jun 25, 2021 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on Jun 29, 2021, To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results/Other business matters | Notice of Board Meeting |
| Financial results | Ind-Swift Laboratories Limited has informed the Exchange about Board Meeting to be held on 28-May-2022 to consider financial statements for the period ended March 2022 |
| Financial results | Ind-Swift Laboratories Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Ind-Swift Laboratories Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results | To consider and approve the financial results for the quarter and financial year ended March 31, 2023 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Other business matters | Prior intimation regarding Board Meeting under Regulation 50(1) |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve, inter alia, the financial results for the period ended December 31, 2024 |
| Financial Results | INDSWFTLAB : 13-Feb-2025 : Intimation / Notice of Adjournment of Board Meeting for consideration of Unaudited Financial Results for the quarter and nine months ended December 31, 2024 and extension of period of Closure of Trading Window. |
Share Transfers of Ind-Swift Laboratories Limited
Voting Results of Ind-Swift Laboratories Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 22-FEB-2025 | Court Convened Meeting | To consider and, if thought fit, approve with or without modification, the arrangement embodied in the Scheme of Arrangement for Amalgamation of Ind-Swift Limited (Transferor Company) with Ind-Swift Laboratories Limited (Transferee Company) and their respective Shareholders and Creditors. |
| 22-FEB-2025 | Court Convened Meeting | To consider and, if thought fit, approve with or without modification, the arrangement embodied in the Scheme of Arrangement for Amalgamation of Ind-Swift Limited (Transferor Company) with Ind-Swift Laboratories Limited (Transferee Company) and their respective Shareholders and Creditors. |
| 30-SEP-2024 | AGM | To receive, consider, approve and adopt the Audited Financial Statements (including Consolidated Financial Statements) for the financial year ended 31st March, 2024 together with the Directors￢ﾀﾙ and Auditors￢ﾀﾙ Reports thereupon. |
| 30-SEP-2024 | AGM | To consider and approve the appointment of and payment of remuneration to Mr. Sahil Munjal (DIN: 00015407), as Whole-Time Director of the Company. |
| 30-SEP-2024 | AGM | Appointment of statutory auditor for a term of 5 (five) consecutive years |
| 30-SEP-2024 | AGM | Appointment of Statutory Auditor to fill casual vacancy. |
| 30-SEP-2024 | AGM | Ratification of remuneration of the cost auditors for the Financial Year 2024-25. |
| 30-SEP-2024 | AGM | To appoint a director in place of Mr. Sahil Munjal (DIN: 00015407), who retires by rotation under the provisions of Companies Act, 2013 and being eligible, offers himself for re-appointment. |
| 22-JUL-2024 | EGM | Issuance of fully convertible warrants to the persons belonging to ￢ﾀﾘpromoter & promoter group￢ﾀﾙ and ￢ﾀﾘnon-promoter￢ﾀﾙ category on preferential basisIssuance of fully convertible warrants to the persons belonging to ￢ﾀﾘpromoter & promoter group￢ﾀﾙ and ￢ﾀﾘnon-promoter￢ﾀﾙ category on preferential basis |
| 22-JUL-2024 | EGM | To appoint Mr. Param Bir Singh (DIN: 07616561) as an independent director of the company |
| 21-JUN-2024 | Postal Ballot | TO INCREASE THE AUTHORISED SHARE CAPITAL OF THE COMPANY AND CONSEQUENTIAL AMENDMENT IN MEMORANDUM OF ASSOCIATION OF THE COMPANY |
| 21-JUN-2024 | Postal Ballot | TO APPROVE MATERIAL MODIFICATION TO THE APPROVED RELATED PARTYnTRANSACTION |
| 21-JUN-2024 | Postal Ballot | TO CONSIDER AND APPROVE ALTERATION IN THE ARTICLES OF ASSOCIATION OFnTHE COMPANY |
| 06-OCT-2023 | EGM | Approval for sale and transfer of Active Pharmaceuticals Ingredients (￢ﾀﾜAPI￢ﾀﾝ) and Contract Research and Manufacturing Services (￢ﾀﾜCRAMS￢ﾀﾝ) Business of the company |
| 06-OCT-2023 | EGM | Approval of the material related party transaction with Ind Swift Limited. |
| 06-OCT-2023 | EGM | Approval of the loan by the company to Ind Swift Limited in terms of the provisions of section 185 of The Companies Act, 2013. |
| 06-OCT-2023 | EGM | To make loan(s) and to give guarantee(s), provide security(ies) or make investment(s) in terms of section 186 of The Companies Act, 2013 |
| 06-OCT-2023 | EGM | Approval for the material related party transaction on account of the transfer of the Active Pharmaceuticals Ingredients (￢ﾀﾜAPI￢ﾀﾝ) and Contract Research and Manufacturing Services (￢ﾀﾜCRAMS￢ﾀﾝ) business of the company |
| 30-SEP-2023 | AGM | TO RECEIVE, CONSIDER, APPROVE AND ADOPT THE AUDITED FINANCIAL STATEMENTS (INCLUDING CONSOLIDATED FINANCIAL STATEMENTS) FOR THE FINANCIAL YEAR ENDED 31ST MARCH, 2023 TOGETHER WITH DIRECTOR'S AND AUDITOR'S REPORT THERETO |
| 30-SEP-2023 | AGM | To appoint a director in place of Mr. Himanshu Jain (DIN:n00014533), who retires by rotation and being eligible, offersnhimself for re-appointment |
FAQs on Ind-Swift Laboratories Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.